Cargando…

Cooperative induction of receptor tyrosine kinases contributes to adaptive MAPK drug resistance in melanoma through the PI3K pathway

Vemurafenib‐induced drug resistance in melanoma has been linked to receptor tyrosine kinase (RTK) upregulation. The MITF and SOX10 genes play roles as master regulators of melanocyte and melanoma development. Here, we aimed to explore the complex mechanisms behind the MITF/SOX10‐controlled RTK‐induc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Alver, Tine Norman, Heintz, Karen‐Marie, Hovig, Eivind, Bøe, Sigurd L.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2022
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9940011/ https://www.ncbi.nlm.nih.gov/pubmed/36251678 http://dx.doi.org/10.1002/cnr2.1736

Ejemplares similares

MITF depletion elevates expression levels of ERBB3 receptor and its cognate ligand NRG1-beta in melanoma
por: Alver, Tine N., et al.
Publicado: (2016)

Dysregulation of MITF Leads to Transformation in MC1R-Defective Melanocytes
por: Lavelle, Timothy J., et al.
Publicado: (2020)

Joint action of miR‐126 and MAPK/PI3K inhibitors against metastatic melanoma
por: Pedini, Francesca, et al.
Publicado: (2019)

Tankyrase inhibition sensitizes melanoma to PD-1 immune checkpoint blockade in syngeneic mouse models
por: Waaler, Jo, et al.
Publicado: (2020)

Computational Modeling of PI3K/AKT and MAPK Signaling Pathways in Melanoma Cancer
por: Pappalardo, Francesco, et al.
Publicado: (2016)

Targeting the MAPK and PI3K pathways in combination with PD1 blockade in melanoma
por: Deken, Marcel A., et al.
Publicado: (2016)

Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
por: Nymark Aasen, Synnøve, et al.
Publicado: (2019)

Melanoma brain colonization involves the emergence of a brain-adaptive phenotype
por: Nygaard, Vigdis, et al.
Publicado: (2014)

In Vitro Treatment of Melanoma Brain Metastasis by Simultaneously Targeting the MAPK and PI3K Signaling Pathways
por: Daphu, Inderjit, et al.
Publicado: (2014)

Fasting potentiates the anticancer activity of tyrosine kinase inhibitors by strengthening MAPK signaling inhibition
por: Caffa, Irene, et al.
Publicado: (2015)

Systems Modeling Identifies Divergent Receptor Tyrosine Kinase Reprogramming to MAPK Pathway Inhibition
por: Claas, Allison M., et al.
Publicado: (2018)

Verbascoside potentiates the effect of tyrosine kinase inhibitors on the induction of apoptosis and oxidative stress via the Abl-mediated MAPK signalling pathway in chronic myeloid leukaemia
por: Akgun-Cagliyan, Gulsum, et al.
Publicado: (2022)

Modulation of β-Catenin Signaling by the Inhibitors of MAP Kinase, Tyrosine Kinase, and PI3-Kinase Pathways
por: Zhang, Wenwen, et al.
Publicado: (2013)

Shikonin inhibits proliferation of melanoma cells by MAPK pathway-mediated induction of apoptosis
por: Lee, Jae Han, et al.
Publicado: (2021)

CIC-Mediated Modulation of MAPK Signaling Opposes Receptor Tyrosine Kinase Inhibitor Response in Kinase-Addicted Sarcoma
por: Odintsov, Igor, et al.
Publicado: (2022)

Phosphatidylinositide 3-kinase (PI3K) and PI3K-related kinase (PIKK) activity contributes to radioresistance in thyroid carcinomas
por: Burrows, Natalie, et al.
Publicado: (2016)

Receptor tyrosine kinase-dependent PI3K activation is an escape mechanism to vertical suppression of the EGFR/RAS/MAPK pathway in KRAS-mutated human colorectal cancer cell lines
por: Vitiello, Pietro Paolo, et al.
Publicado: (2019)

Abl Kinase Regulation by BRAF/ERK and Cooperation with Akt in Melanoma
por: Jain, Aditi, et al.
Publicado: (2017)

Tyrosine kinase inhibitors as induction therapy in nonsmall-cell lung cancer
por: Gong, Juejun, et al.
Publicado: (2021)

Role of the HGF/c-MET tyrosine kinase inhibitors in metastasic melanoma
por: Demkova, Lucia, et al.
Publicado: (2018)

Redox-Sensitive Induction of Src/PI3-kinase/Akt and MAPKs Pathways Activate eNOS in Response to EPA:DHA 6:1
por: Zgheel, Faraj, et al.
Publicado: (2014)

MUTYH Mutations Do Not Cause HNPCC or Late Onset Familial Colorectal Cancer
por: Stormorken, Astrid, et al.
Publicado: (2006)

Integration of Receptor Tyrosine Kinases Determines Sensitivity to PI3Kα-selective Inhibitors in Breast Cancer
por: Xu, Yi-chao, et al.
Publicado: (2017)

The transcription factor RUNX2 regulates receptor tyrosine kinase expression in melanoma
por: Boregowda, Rajeev K., et al.
Publicado: (2016)

Expression and Prognostic Evaluation of the Receptor Tyrosine Kinase MET in Canine Malignant Melanoma
por: Koo, Karen, et al.
Publicado: (2023)

Cooperation of imipramine blue and tyrosine kinase blockade demonstrates activity against chronic myeloid leukemia
por: Laidlaw, Kamilla M.E., et al.
Publicado: (2016)

PI3K/AKT signaling allows for MAPK/ERK pathway independency mediating dedifferentiation-driven treatment resistance in melanoma
por: Corrales, Eyleen, et al.
Publicado: (2022)

Assembly of nuclear dimers of PI3K regulatory subunits is regulated by the Cdc42-activated tyrosine kinase ACK
por: Clayton, Natasha S., et al.
Publicado: (2022)

Induction of Apoptosis after Expression of PYK2, a Tyrosine Kinase Structurally Related to Focal Adhesion Kinase
por: Xiong, Wen-cheng, et al.
Publicado: (1997)

FGF mediated MAPK and PI3K/Akt Signals make distinct contributions to pluripotency and the establishment of Neural Crest
por: Geary, Lauren, et al.
Publicado: (2018)

Antimetabolic cooperativity with the clinically approved l-asparaginase and tyrosine kinase inhibitors to eradicate CML stem cells
por: Trinh, Anne, et al.
Publicado: (2021)

FAM83B-mediated activation of PI3K/AKT and MAPK signaling cooperates to promote epithelial cell transformation and resistance to targeted therapies
por: Cipriano, Rocky, et al.
Publicado: (2013)

Stitchprofiles.uio.no: analysis of partly melted DNA conformations using stitch profiles
por: Tøstesen, Eivind, et al.
Publicado: (2005)

A Novel Small Molecule Antagonist of Choline Kinase-α That Simultaneously Suppresses MAPK and PI3K/AKT Signaling
por: Clem, Brian F., et al.
Publicado: (2011)

Differential Effects of p38, MAPK, PI3K or Rho Kinase Inhibitors on Bacterial Phagocytosis and Efferocytosis by Macrophages in COPD
por: Bewley, Martin A., et al.
Publicado: (2016)

Options available for profiling small samples: a review of sample amplification technology when combined with microarray profiling
por: Nygaard, Vigdis, et al.
Publicado: (2006)

Differential Protein Network Analysis of the Immune Cell Lineage
por: Clancy, Trevor, et al.
Publicado: (2014)

The BRCA2 variant c.68-7 T>A is associated with breast cancer
por: Møller, Pål, et al.
Publicado: (2017)

Retraction Note to: The BRCA2 variant c.68–7 T > A is associated with breast cancer
por: Møller, Pål, et al.
Publicado: (2018)

Our genes, our selves: hereditary breast cancer and biological citizenship in Norway
por: Møller, Pål, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_erh33mqpua1b04adr4bf1arg02